Resources from the same session
Current status of (neo) adjuvant immunotherapy in early stage NSCLC
Presenter: Lizza Hendriks
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Slides
Webcast
Early stage NSCLC immunotherapy: Which biomarkers matter?
Presenter: Julie Brahmer
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Slides
Webcast
Dealing with comorbidities and toxicities in stage I-III NSCLC
Presenter: Dirk De Ruysscher
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Maarten Lambrecht
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Webcast